证券代码：301228 证券简称：实朴检测 公告编号：2023-049 实朴检测技术（上海）股份有限公司 关于部分募投项目延期的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 实朴检测技术（上海）股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日召开了第二届董事会第六次会议和第二届监事会第五次会议，分别审议通 过了《关于部分募投项目延期的议案》，同意公司对募投项目"中春路新建实验 室项目"、"研发信息中心建设项目"的达到预定可使用状态日期调整至 2024 年 12 月 31 日。公司独立董事对本事项发表了明确同意的独立意见，保荐机构海 通证券股份有限公司对本事项出具了无异议的核查意见，该事项无需提交公司股 东大会审议。现将具体情况公告如下： 一、募集资金基本情况 根据中国证券监督管理委员会于 2021 年 12 月 21 日核发的"证监许可 [2021]4041 号"文《关于同意实朴检测技术（上海）股份有限公司首次公开发 行股票注册的批复》，实朴检测技术（上海）股份有限公司获准向社会公开发行 人民币普通股股票 3,000.00 万股，每股 ...

证券代码：301228 证券简称：实朴检测 公告编号：2023-043 实朴检测技术（上海）股份有限公司 4.承诺、计划等履行情况 本次变动是否为履行已作 出的承诺、意向、计划 是☑否□ 关于持股 5%以上股东 及其一致行动人减持股份达到 1%的公告 持股5%以上的股东镇江沃土一号基金合伙企业（有限合伙）及其一致行动人上海锡惠投资有限公司保 证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 公司于近日收到镇江沃土一号基金合伙企业（有限合伙）（以下简称"镇江 沃土"）及其一致行动人上海锡惠投资有限公司（以下简称"锡惠投资"）出具 的《减持股份比例达到 1%的告知函》，2023 年 4 月 28 日至 2023 年 8 月 23 日 期间，镇江沃土及锡惠投资通过集中竞价交易方式累计减持公司股票 1,261,327 股，占公司总股本的 1.0511%。现将具体情况公告如下： | 1.基本情况 | | | | | | --- | --- | --- | --- | --- | | 信息披露义务人（一） | 镇江沃土一号基 ...

证券代码：301228 证券简称：实朴检测 实朴检测技术(上海)股份有限公司 投资者关系活动记录表 编号：2023-002 | 投资者关系活动类别 | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位名称及人员 | 线上参与公司2022年年度业绩说明会的全体投资者 | | 姓名 | | | 时间 | 2023年05月18日 15:00-17:00 | | 地点 | 价值在线（https://www.ir-online.cn/）网络互动 | | 上市公司接待人员姓名 | 董事长兼总经理 杨进 | | | 董事、副总经理、董事会秘书 叶琰 | | | 独立董事 李金桂 | | | 财务负责人 韦柳 | | | 1.我有个好奇的问题，公司主营业务为从事环境检 | | | 测和食品检测，检测手段多为四大谱，公司的控制股东 | | 投资者关系活动主要 | 为实谱(上海)企业管理有限公司，为什么却给上市公司 | | 内容介绍 | 取名为实朴检测，依我投 ...

关于举办 2022 年年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 实朴检测技术(上海)股份有限公司（以下简称"公司"）已于 2023 年 04 月 27 日在巨潮资讯网（www.cninfo.com.cn）上披露了《2022 年年度报告》及《2022 年年度报告摘要》。为便于广大投资者更加全面深入地了解公司经营业绩、发展 战略等情况，公司定于 2023 年 05 月 18 日（星期四）15:00-17:00 在"价值在线" （www.ir-online.cn）举办实朴检测技术(上海)股份有限公司 2022 年年度业绩说 明会，与投资者进行沟通和交流，广泛听取投资者的意见和建议。 会议召开时间：2023 年 05 月 18 日（星期四）15:00-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会 议 问 题 征集 ： 投 资者 可 于 2023 年 05 月 18 日 前访问网址 https://eseb.cn/14tTHPgFwsw 或使用微信扫描下方小程序码进行会 ...

Financial Performance - The company's operating revenue for 2022 was ¥351,469,621.35, a decrease of 17.28% compared to ¥424,866,246.46 in 2021[24]. - The net profit attributable to shareholders was -¥18,072,053.58 in 2022, representing a decline of 135.83% from ¥50,432,176.02 in 2021[24]. - The cash flow from operating activities was ¥7,820,592.65, down 90.96% from ¥86,525,116.26 in the previous year[24]. - The total assets at the end of 2022 amounted to ¥1,235,383,012.54, an increase of 82.90% from ¥675,441,274.57 at the end of 2021[24]. - The net assets attributable to shareholders increased by 114.04% to ¥909,438,844.45 at the end of 2022 from ¥424,897,989.06 at the end of 2021[24]. - The basic and diluted earnings per share were both -¥0.15 in 2022, a decrease of 126.79% from ¥0.56 in 2021[24]. - The company reported a significant drop in net profit after deducting non-recurring gains and losses, which was -¥31,460,005.93 in 2022 compared to ¥48,108,428.71 in 2021, a decline of 165.39%[24]. - The company achieved a total revenue of ¥351,469,621.35 in 2022, a decrease of 17.28% compared to ¥424,866,246.46 in 2021[59]. - The gross profit margin for the professional technical services sector was 33.43%, reflecting a decrease of 6.88% from the previous year[60]. Operational Challenges - The company's performance in 2022 significantly declined due to economic downturn, with increased accounts receivable and longer aging, leading to a year-on-year increase in asset impairment provisions[4]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profits over the last three accounting years[24]. - The company acknowledges uncertainties in future plans and projections, which depend on market conditions and do not constitute a commitment to investors[4]. - The management discussion highlights potential risks in operations and corresponding countermeasures[6]. - The company aims to improve operational performance amidst challenging market conditions[4]. Strategic Focus and Development - Despite the decline, the company's core competitiveness and technological advantages remain intact, with no significant risk to its ongoing operations[4]. - The company plans to focus on its main business to enhance its industry position, competitive capabilities, and sustainable development as the economy recovers[4]. - The company continues to explore new strategies for market expansion and technological development[4]. - The company is committed to high-quality development and has aligned its operations with national policies on quality infrastructure and environmental protection[39]. - The company aims to enhance its service offerings by providing value-added services based on foundational testing data, including technical consulting and online monitoring[45]. Research and Development - The company has established over 70 R&D projects focused on soil detection, emphasizing the development of methods for non-standard compounds and characteristic pollutants[43]. - The company has developed analysis capabilities for new pollutants, covering 14 types of key controlled pollutants, and is actively working on new detection technologies[46]. - R&D investment reached ¥41,934,521.52 in 2022, accounting for 11.93% of operating revenue, up from 7.42% in 2021[70]. - R&D personnel increased to 218 in 2022, a 77.24% increase from 123 in 2021, with R&D personnel now representing 18.74% of the total workforce[70]. - The company is developing new detection technologies for organic pollutants in soil, which is expected to enhance its service capabilities[69]. Market Position and Expansion - The company has a strong market position in the third-party testing industry, recognized for its expertise in soil pollution surveys and environmental monitoring[39]. - The company aims to expand its laboratory testing range and service capabilities, targeting a comprehensive testing platform through both organic growth and acquisitions[101]. - The company plans to enhance its capabilities in soil and groundwater testing through increased R&D efforts and expansion of business operations[71]. - The company plans to expand its market presence in Southeast Asia, targeting a 20% market share within the next two years[182]. - A strategic acquisition of a local competitor is anticipated to be finalized by Q3 2023, expected to increase market penetration by 15%[183]. Financial Management and Governance - The company maintains its commitment to transparency and accuracy in financial reporting, as affirmed by its board and management[4]. - The company has established a comprehensive internal control system to ensure the effectiveness of business activities and the integrity of financial reporting[142]. - The company has a governance structure that includes independent directors, ensuring compliance with legal and regulatory requirements[110]. - The company has established a professional team for systematic management of accounts receivable to ensure smooth cash flow[104]. - The company has implemented a dual-level transaction authorization system to ensure that transactions are conducted within authorized limits[152]. Investor Relations and Shareholder Engagement - The company emphasizes the importance of maintaining brand credibility and public trust, implementing strict quality control measures to ensure data authenticity[102]. - The company has developed an information disclosure management system to protect investor rights and ensure timely and accurate information dissemination[172]. - The company adheres to national laws and regulations regarding information disclosure, ensuring compliance and transparency[174]. - The company will ensure compliance with all legal and regulatory requirements regarding shareholding and share changes[181]. - The company will publicly explain any failure to fulfill commitments made regarding shareholding[181]. Social Responsibility and Compliance - The company emphasizes social responsibility, focusing on environmental protection and health safety in its testing services[172]. - The company actively participates in social responsibility initiatives, including support for disadvantaged groups and charitable activities[176]. - The company will ensure compliance with social security and housing fund regulations for all employees[192]. - The company is dedicated to becoming a "best employer" by providing a good working environment and cultural activities for employees[175]. - The company will not engage in any form of fund occupation with its subsidiaries, ensuring compliance with relevant regulations[192].

Financial Performance - The company's revenue for Q1 2023 was ¥70,592,312.87, representing a 28.65% increase compared to ¥54,871,245.63 in the same period last year[5] - The net loss attributable to shareholders was ¥20,304,754.46, which is a 40.51% increase from a loss of ¥14,450,472.41 in the previous year[5] - Basic and diluted earnings per share were both -¥0.1692, a decrease of 30.15% from -¥0.1300 in the same quarter last year[5] - The company reported a net loss for Q1 2023, with net profit margin declining compared to the previous year[23] - The net profit for Q1 2023 was -¥20,020,190.67, compared to -¥14,687,406.57 in Q1 2022, representing a year-over-year increase in net loss of approximately 36.5%[24] - Operating profit for Q1 2023 was -¥25,403,056.25, compared to -¥19,086,184.00 in the same period last year, indicating a worsening of approximately 33.5%[24] - The total comprehensive loss for Q1 2023 was -¥20,020,190.67, compared to -¥14,687,406.57 in the same quarter last year, representing an increase in comprehensive loss of approximately 36.5%[25] - The company reported a total profit loss of -¥25,462,578.94 for Q1 2023, compared to -¥19,086,197.18 in Q1 2022, reflecting a worsening of approximately 33.5%[24] Cash Flow and Investments - The net cash flow from operating activities improved by 6.77%, amounting to -¥30,959,786.30 compared to -¥33,206,985.75 in Q1 2022[5] - Cash flow from operating activities showed a net outflow of -¥30,959,786.30, an improvement from -¥33,206,985.75 in Q1 2022[26] - Total cash inflow from investment activities was ¥346,842,621.06, significantly higher than ¥40,053,397.64 in the previous year, marking an increase of approximately 767.5%[28] - The total cash outflow from investment activities was ¥278,721,080.77, compared to ¥482,865,720.22 in the previous year, indicating a decrease of approximately 42.4%[28] - The company reported cash and cash equivalents at the end of Q1 2023 amounting to ¥202,548,862.69, up from ¥154,313,665.74 at the end of Q1 2022, reflecting a year-over-year increase of about 31.2%[28] Operating Costs and Revenue - The company reported a significant increase in operating costs, which rose by 55.99% to ¥61,160,791.59 due to the addition of new subsidiaries and personnel[10] - Total operating revenue for Q1 2023 reached ¥70,592,312.87, an increase of 28.5% compared to ¥54,871,245.63 in Q1 2022[23] - Total operating costs for Q1 2023 were ¥96,479,401.41, up 42% from ¥68,035,580.07 in the same period last year[23] - Gross profit margin decreased to approximately 26.5% in Q1 2023 from 28.5% in Q1 2022[23] - The company generated ¥85,548,823.12 in cash from sales and services in Q1 2023, compared to ¥46,913,268.09 in Q1 2022, showing an increase of approximately 82.2%[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,207,522,561.36, down 2.26% from ¥1,235,383,012.54 at the end of the previous year[5] - Total assets as of March 31, 2023, were ¥1,207,522,561.36, a decrease from ¥1,235,383,012.54 at the beginning of the year[21] - Total liabilities increased by 25.45% to ¥37,699,943.14 due to customer prepayments[10] - Total liabilities decreased to ¥260,303,984.03 from ¥268,144,244.54 at the beginning of the year[21] - Non-current assets totaled ¥350,491,409.13, slightly up from ¥345,290,484.07 at the beginning of the year[20] Shareholder Information - The company reported a total of 52,003,313 shares outstanding, with the largest shareholder holding 43.34%[13] - The top ten shareholders include Zhenjiang Wotu No.1 Fund Partnership with 7,900,575 shares (6.58%) and Longzheng Environmental Co., Ltd. with 3,187,328 shares (2.66%)[13] - The company has a total of 1,861,349 shares (1.55%) held by Jiangsu Huayang Metal Pipe Co., Ltd.[13] - All shares held by the top shareholders are subject to lock-up agreements, with the first release date set for January 30, 2023[16] - The company’s actual controllers are Yang Jin and Wu Yaohua, holding 66.00% and 20.00% of shares respectively[14] - The company has not disclosed any related party transactions among its shareholders[14] - The total number of shares held by the top ten shareholders with unrestricted conditions is 7,900,575 shares[16] - The company has a total of 811,475 shares held by Wuhan Yinxin Computing Data Service Co., Ltd.[16] - The company’s stock structure includes various private equity and investment partnerships as significant shareholders[13] - The company is focused on maintaining a stable shareholder structure while exploring potential market expansions[14] Research and Development - Research and development expenses for Q1 2023 were ¥12,336,723.37, compared to ¥12,822,875.15 in Q1 2022, indicating a decrease of 3.8%[23] - The company plans to focus on market expansion and new product development in the upcoming quarters[20]

Group 1: Company Overview - Shihpu Testing is a comprehensive third-party testing organization that started with soil and groundwater testing, expanding its services to various sectors including environmental, solid waste, agricultural products, consumer goods, cosmetics, dioxins, occupational health, and medical testing [2]. - The company has established multiple laboratories and liaison offices in key regions such as Jiangsu, Zhejiang, Shanghai, Tianjin, Shanxi, Guangdong, and Sichuan, covering 31 provinces, municipalities, and autonomous regions, including 1 special administrative region [2][3]. Group 2: Business Performance and Capacity - The company has successfully included 8 laboratories in the list for the third national soil survey, as announced by the Ministry of Agriculture and Rural Affairs [3]. - Soil and groundwater testing accounts for approximately 90% of the company's main business revenue [3]. Group 3: Future Development and Strategy - The company plans to extend its testing services to chemical products, materials, biology, and calibration, while also pursuing market expansion through mergers and acquisitions [3][4]. - The company is focused on talent acquisition and training, with a current workforce of over 1,200 employees, and plans to increase recruitment in line with business needs and future development expectations [4]. Group 4: Clientele and Financial Health - The main clients include government agencies, consulting firms, remediation companies, industrial enterprises, and educational institutions, with a strong credit profile and low bad debt risk [4]. - The company emphasizes a long repayment cycle with low credit risk, primarily relying on government financial resources for project funding [4].

实朴检测技术（上海）股份有限公司 2022 年第三季度报告 证券代码：301228 证券简称：实朴检测 公告编号：2022-051 实朴检测技术（上海）股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 实朴检测技术（上海）股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 适用 □不适用 实朴检测技术（上海）股份有限公司 2022 年第三季度报告 | （税后） | | | | | --- | --- | --- | --- | | 合计 | 3,663,782.67 | 8,428,229.33 | -- | | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说 ...

Financial Performance - The company reported a revenue of RMB 100 million for the first half of 2022, representing a year-on-year increase of 20%[18]. - The net profit attributable to shareholders for the same period was RMB 15 million, up 25% compared to the previous year[18]. - Future guidance indicates a revenue target of RMB 220 million for the full year 2022, reflecting a growth rate of 15%[18]. - The company's operating revenue for the reporting period was ¥121,530,611.30, a decrease of 25.89% compared to ¥163,990,661.80 in the same period last year[24]. - The net profit attributable to shareholders was -¥32,059,814.24, representing a decline of 396.33% from ¥10,819,129.16 in the previous year[24]. - The net cash flow from operating activities was -¥36,691,393.59, a decrease of 661.09% compared to ¥6,539,344.06 in the same period last year[24]. - The company reported a significant increase in trading financial assets, totaling ¥370,000,000, which accounted for 33.41% of total assets, primarily due to the purchase of structured deposit financial products[53]. - The company reported a net profit of -18,457,579.64 yuan for the first half of 2022, compared to a net profit of 10,088,919.53 yuan in the same period of 2021, indicating a significant decline in profitability[161]. - The total comprehensive income for the period was -18,457,579.64 yuan, reflecting the overall financial challenges faced by the company[162]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 15% market share by the end of 2023[18]. - The company is exploring potential acquisitions to enhance its service offerings, with a budget of RMB 50 million allocated for this purpose[18]. - The company is actively expanding its services in occupational health, consumer products, medical devices, materials, metrology, radiation, ecological products, and carbon verification[34]. - The company is focused on expanding its market presence and enhancing its service offerings in the environmental testing sector[108]. - The company has established a strategic plan for market expansion and potential mergers and acquisitions in the future[108]. - The company is committed to ongoing research and development of new technologies and products to maintain competitive advantage[108]. - The company plans to enhance laboratory process reforms and improve testing efficiency to control costs and ensure data accuracy, thereby avoiding unnecessary expenses[78]. Research and Development - New product development includes a state-of-the-art testing technology expected to launch in Q4 2022, projected to increase revenue by 10%[18]. - The management highlighted ongoing research and development efforts, with an investment of RMB 8 million in new technologies during the first half of 2022[18]. - The company's R&D investment increased by 48.15% to CNY 26,448,933.47, up from CNY 17,852,522.62, reflecting a focus on enhancing research projects[47]. - The company emphasizes technological research and development, continuously optimizing testing methods and expanding its capabilities in environmental testing standards[43]. - The company has allocated resources for research and development of new products, aiming to enhance its competitive edge in the market[171]. Operational Challenges - The COVID-19 pandemic has significantly impacted the company's operations, with challenges in supply chain, logistics, and project implementation, leading to a risk of substantial performance decline for the year[80]. - The company faces risks of declining performance due to potential adverse changes in industry policies and increased competition, which could lead to lower order acquisition and higher costs[78]. - The company is closely monitoring industry policy changes and actively adapting to mitigate potential risks associated with regulatory shifts[79]. - The company is enhancing its collection efforts on aged receivables to mitigate the risk of bad debts, ensuring smooth financial operations[79]. Asset and Equity Management - Total assets increased by 63.95% to ¥1,107,385,299.91 from ¥675,441,274.57 at the end of the previous year[24]. - The net assets attributable to shareholders rose by 110.68% to ¥895,171,643.46 from ¥424,897,989.06 at the end of the previous year[24]. - The company's total assets at the end of the reporting period amounted to ¥1,107,000,000, with cash and cash equivalents constituting 14.69% of total assets, a decrease of 1.05% from the previous year[53]. - The company's total liabilities decreased to CNY 192,860,979.41 from CNY 231,082,463.77, a reduction of about 16.5%[151]. - Shareholders' equity rose significantly to CNY 914,524,320.50 from CNY 444,358,810.80, marking an increase of approximately 105.5%[151]. Quality Control and Compliance - The company implemented a strict quality control system across all laboratory processes, ensuring the authenticity and objectivity of the reports issued[45]. - The company strictly adhered to environmental protection laws and did not face any administrative penalties related to environmental issues during the reporting period[91]. - The company emphasizes social responsibility and aims to become a benchmark in the inspection and testing industry, focusing on environmental protection and health safety[92]. Shareholder and Financial Structure - The company completed its initial public offering (IPO) of 30,000,000 shares, which began trading on January 28, 2022, on the Shenzhen Stock Exchange, resulting in a total share capital of 120,000,000 shares[122]. - The company distributed cash dividends of 2 RMB per 10 shares to all shareholders, totaling 24,000,000 RMB (including tax) based on the total share capital of 120,000,000 shares[122]. - The company’s shareholding structure includes 93,795,600 shares (78.16%) held by limited sale condition shares and 26,204,300 shares (21.84%) held by unrestricted shares[126]. - The company has not reported any significant changes in the measurement attributes of its major assets during the reporting period[57]. - The company has not engaged in any derivative investments during the reporting period[70].